TAZEMETOSTAT HYDROBROMIDE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 102 adverse event reports in the FDA FAERS database where TAZEMETOSTAT HYDROBROMIDE was used for Off label use.
Most Reported Side Effects for TAZEMETOSTAT HYDROBROMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 298 | 22.5% | 60 | 48 |
| Fatigue | 292 | 22.1% | 10 | 41 |
| Disease progression | 267 | 20.2% | 44 | 44 |
| Nausea | 207 | 15.7% | 12 | 31 |
| Product dose omission issue | 183 | 13.8% | 4 | 32 |
| Death | 106 | 8.0% | 105 | 27 |
| Diarrhoea | 100 | 7.6% | 2 | 11 |
| Decreased appetite | 81 | 6.1% | 4 | 17 |
| Asthenia | 75 | 5.7% | 5 | 29 |
| Vomiting | 75 | 5.7% | 8 | 16 |
| Constipation | 66 | 5.0% | 2 | 5 |
| Covid-19 | 65 | 4.9% | 4 | 30 |
| Alopecia | 61 | 4.6% | 2 | 8 |
| Headache | 61 | 4.6% | 3 | 5 |
| Pain | 58 | 4.4% | 5 | 17 |
Other Indications for TAZEMETOSTAT HYDROBROMIDE
Follicular lymphoma (439)
Soft tissue sarcoma (298)
B-cell lymphoma (91)
Malignant connective tissue neoplasm (72)
Product used for unknown indication (54)
Epithelioid sarcoma (46)
Follicular lymphoma stage ii (38)
Follicular lymphoma stage i (34)
Brain neoplasm malignant (31)
Neoplasm malignant (23)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)